What is MicrobiomX?
MicrobiomX is a company dedicated to advancing fecal microbiota transplantation (FMT) and gut microbiome health through cutting-edge solutions. The company offers a proprietary device designed for the efficient collection and preparation of microbiome material from stool. This innovation aims to simplify the utilization of this natural healing resource for researchers, clinicians, and patients alike. MicrobiomX also provides comprehensive microbiome testing and reporting services, with the overarching goal of enhancing health outcomes. Their expertise extends to animal health through a dedicated subsidiary, Amend Pet, demonstrating a broad application of their microbiome science.
How much funding has MicrobiomX raised?
MicrobiomX has raised a total of $1M across 1 funding round:
Other Financing Round
$1M
Other Financing Round (2021): $1M, investors not publicly disclosed
What's next for MicrobiomX?
The substantial enterprise-level funding and recent strategic investment position MicrobiomX for accelerated growth and further development of its microbiome technologies. This capital infusion is expected to fuel advancements in their FMT solutions, expand their testing and reporting capabilities, and potentially broaden their market reach in both human and animal health sectors. The company's focus on innovative devices and comprehensive services suggests a strategy aimed at becoming a leader in the rapidly evolving field of microbiome therapeutics and diagnostics.
See full MicrobiomX company page
